Benign hereditary chorea

Benign hereditary chorea
Synonyms	BHC, Non-progressive chorea
Pronounce	N/A
Specialty	N/A
Symptoms	Chorea, Ataxia, Hypotonia, Respiratory distress
Complications	N/A
Onset	Infancy or early childhood
Duration	Lifelong
Types	N/A
Causes	Genetic mutation in the NKX2-1 gene
Risks	Family history of the condition
Diagnosis	Clinical evaluation, Genetic testing
Differential diagnosis	Huntington's disease, Sydenham's chorea, Wilson's disease
Prevention	N/A
Treatment	Symptomatic treatment, Physical therapy
Medication	N/A
Prognosis	Generally benign with normal life expectancy
Frequency	Rare
Deaths	N/A

A rare genetic movement disorder

Benign hereditary chorea (BHC) is a rare genetic disorder characterized by early-onset chorea, a type of movement disorder that involves involuntary, irregular, and unpredictable muscle movements. BHC is considered "benign" because it does not typically progress to more severe neurological conditions, unlike other forms of chorea.

Etiology

Benign hereditary chorea is primarily caused by mutations in the NKX2-1 gene, also known as the TITF1 gene, located on chromosome 14. This gene is crucial for the development of the brain, thyroid, and lungs. Mutations in NKX2-1 can lead to a triad of symptoms affecting these organs, although in BHC, the primary manifestation is neurological.

Clinical Features

The hallmark of BHC is the presence of chorea, which typically presents in childhood. The movements are often described as "dance-like" and can affect various parts of the body, including the face, trunk, and limbs.

Neurological Symptoms

- Chorea: Involuntary, rapid, and irregular movements. - Hypotonia: Decreased muscle tone, which may be present in some individuals. - Mild developmental delay: Some children may experience delays in reaching motor milestones.

Non-neurological Symptoms

While BHC primarily affects movement, some individuals may also experience: - Thyroid dysfunction: Such as hypothyroidism or hyperthyroidism. - Respiratory issues: Due to the involvement of the lungs, although this is less common.

Diagnosis

Diagnosis of benign hereditary chorea is based on clinical evaluation, family history, and genetic testing. The presence of chorea in a child with a family history of similar symptoms may prompt genetic testing for mutations in the NKX2-1 gene.

Management

There is no cure for BHC, but management focuses on alleviating symptoms and improving quality of life. Treatment options may include: - Medications: Such as dopamine antagonists or benzodiazepines to help control chorea. - Physical therapy: To improve motor skills and muscle strength. - Regular monitoring: For thyroid function and respiratory health.

Prognosis

The prognosis for individuals with benign hereditary chorea is generally favorable. While the chorea can be persistent, it does not typically worsen over time, and many individuals lead normal lives. However, associated conditions such as thyroid dysfunction may require ongoing management.

Related pages

• Chorea
• Genetic disorder
• Movement disorder
• NKX2-1 gene